허수진
#입원환자 전담 전문의#종양내과 전문의#항암약물치료#신약치료 및 완화의료
|
학력
연세대학교 원주의과대학 학사 (2010)
연세대학교 의학과 석사 (2016)
연세대학교 의학과 석사 (2016)
경력
2010.3~2011.2 세브란스병원 인턴 수료
2011.3~2015.2 세브란스병원 내과 전공의 수료
2015.3~2016.2 세브란스병원 종양내과 강사
2016.3~ 현재 연세암병원 입원전담전문의
2011.3~2015.2 세브란스병원 내과 전공의 수료
2015.3~2016.2 세브란스병원 종양내과 강사
2016.3~ 현재 연세암병원 입원전담전문의
논문
● Risk Factors and Prognosis of Pulmonary Complications After Endoscopic Submucosal Dissection for Gastric Neoplasia
DIGESTIVE DISEASES AND SCIENCES. 58/2 :540-6,2013
● Prediction of short- and long-term survival for advanced cancer patients after ICU admission
SUPPORTIVE CARE IN CANCER. 23/6 :1647-55,2015
● Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients who Failed First-line Therapy Containing Darcabazine
CANCER RESEARCH AND TREATMENT. 47/4 :781-9,2015
● The Clinicopathologic Features and Prognostic Impact of Positivity in Patients with Resected Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY. 22/12 :3938-45,2015
● A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
CANCER RESEARCH AND TREATMENT. 48/1 :409-14,2016
● Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
ANNALS OF SURGERY. 263/1 :96-102,2016
● A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
CANCER CHEMOTHERAPY AND PHARMACOLOGY. 77/3 :539-48,2016
● Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
ONCOLOGY 96/2 :59-69,2019
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
YONSEI MEDICAL JOURNAL 60/6 :525-534,2019
Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma
CANCER RESEARCH AND TREATMENT 50/4 :1238-1251,2018
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
ANNALS OF SURGICAL ONCOLOGY 25/11 :3,222-3,230,2018
PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
ONCOTARGET 8/69 :113,494-113,501,2017
Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma
APMIS 125/11 :974-984,2017
Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis.
ONCOTARGET 8/39 :65,111-65,122,2017
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
ONCOTARGET 8/37 :61,837-61,845,2017
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
BMC CANCER 17/615 :615-625,2017
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer
ANNALS OF SURGICAL ONCOLOGY 24/1 :227-235,2017
Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.
ONCOTARGET 8/19 :31,169-31,179,2017
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE 2/5 :a000992-,2016
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
JOURNAL OF BREAST CANCER 19/1 :76-82,2016
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
SCIENTIFIC REPORTS 6/36956 :1-12,2016
Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08.
CANCER RESEARCH AND TREATMENT 48/4 :1,286-1,292,2016
Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer
ANNALS OF SURGICAL ONCOLOGY 23/ :928-935,2016
Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
JOURNAL OF CANCER 7/15 :2,197-2,206,2016
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 77/3 :539-548,2016
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
BRITISH JOURNAL OF CANCER 115/1 :25-33,2016
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
ANNALS OF SURGERY 263/1 :96-102,2016
A Case of von Hippel?Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
CANCER RESEARCH AND TREATMENT 48/1 :409-414,2016
Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
CANCER RESEARCH AND TREATMENT 74/4 :781-789,2015
The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 22/12 :3938-3945,2015
Prediction of short- and long-term survival for advanced cancer patients after ICU admission
SUPPORTIVE CARE IN CANCER 23/6 :1647-1655,2015
Risk Factors and Prognosis of Pulmonary Complications After Endoscopic Submucosal Dissection for Gastric Neoplasia
DIGESTIVE DISEASES AND SCIENCES 58/2 :540-546,2013
DIGESTIVE DISEASES AND SCIENCES. 58/2 :540-6,2013
● Prediction of short- and long-term survival for advanced cancer patients after ICU admission
SUPPORTIVE CARE IN CANCER. 23/6 :1647-55,2015
● Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients who Failed First-line Therapy Containing Darcabazine
CANCER RESEARCH AND TREATMENT. 47/4 :781-9,2015
● The Clinicopathologic Features and Prognostic Impact of Positivity in Patients with Resected Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY. 22/12 :3938-45,2015
● A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
CANCER RESEARCH AND TREATMENT. 48/1 :409-14,2016
● Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
ANNALS OF SURGERY. 263/1 :96-102,2016
● A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
CANCER CHEMOTHERAPY AND PHARMACOLOGY. 77/3 :539-48,2016
● Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
ONCOLOGY 96/2 :59-69,2019
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
YONSEI MEDICAL JOURNAL 60/6 :525-534,2019
Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma
CANCER RESEARCH AND TREATMENT 50/4 :1238-1251,2018
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
ANNALS OF SURGICAL ONCOLOGY 25/11 :3,222-3,230,2018
PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
ONCOTARGET 8/69 :113,494-113,501,2017
Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma
APMIS 125/11 :974-984,2017
Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis.
ONCOTARGET 8/39 :65,111-65,122,2017
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
ONCOTARGET 8/37 :61,837-61,845,2017
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
BMC CANCER 17/615 :615-625,2017
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer
ANNALS OF SURGICAL ONCOLOGY 24/1 :227-235,2017
Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.
ONCOTARGET 8/19 :31,169-31,179,2017
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE 2/5 :a000992-,2016
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
JOURNAL OF BREAST CANCER 19/1 :76-82,2016
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
SCIENTIFIC REPORTS 6/36956 :1-12,2016
Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08.
CANCER RESEARCH AND TREATMENT 48/4 :1,286-1,292,2016
Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer
ANNALS OF SURGICAL ONCOLOGY 23/ :928-935,2016
Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
JOURNAL OF CANCER 7/15 :2,197-2,206,2016
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 77/3 :539-548,2016
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
BRITISH JOURNAL OF CANCER 115/1 :25-33,2016
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
ANNALS OF SURGERY 263/1 :96-102,2016
A Case of von Hippel?Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
CANCER RESEARCH AND TREATMENT 48/1 :409-414,2016
Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
CANCER RESEARCH AND TREATMENT 74/4 :781-789,2015
The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 22/12 :3938-3945,2015
Prediction of short- and long-term survival for advanced cancer patients after ICU admission
SUPPORTIVE CARE IN CANCER 23/6 :1647-1655,2015
Risk Factors and Prognosis of Pulmonary Complications After Endoscopic Submucosal Dissection for Gastric Neoplasia
DIGESTIVE DISEASES AND SCIENCES 58/2 :540-546,2013
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.